Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin K
- PMID: 28300073
- PMCID: PMC5353622
- DOI: 10.1038/srep41710
Actin-binding protein coronin 1A controls osteoclastic bone resorption by regulating lysosomal secretion of cathepsin K
Abstract
Osteoclasts degrade bone matrix proteins via the secretion of lysosomal enzymes. However, the precise mechanisms by which lysosomal components are transported and fused to the bone-apposed plasma membrane, termed ruffled border membrane, remain elusive. Here, we identified coronin 1A as a negative regulator of exocytotic release of cathepsin K, one of the most important bone-degrading enzymes in osteoclasts. The modulation of coronin 1A expression did not alter osteoclast differentiation and extracellular acidification, but strongly affected the secretion of cathepsin K and osteoclast bone-resorption activity, suggesting the coronin 1A-mediated regulation of lysosomal trafficking and protease exocytosis. Further analyses suggested that coronin 1A prevented the lipidation-mediated sorting of the autophagy-related protein LC3 to the ruffled border and attenuated lysosome-plasma membrane fusion. In this process, the interactions between coronin 1A and actin were crucial. Collectively, our findings indicate that coronin 1A is a pivotal component that regulates lysosomal fusion and the secretion pathway in osteoclast-lineage cells and may provide a novel therapeutic target for bone diseases.
Conflict of interest statement
S.O., T.F. and M. Asagiri were partly employed by the Coordination Fund from the Japan Science and Technology Agency and Astellas Pharma Inc.; and T.F. and M. Asagiri received research grants from this fund. K.I. is employed by the Coordination Fund from Kyoto University and Chugai Pharmaceutical Co., Ltd.; and receive research grants from this fund. The authors have no additional conflict of interests.
Figures






Similar articles
-
V-ATPase subunit ATP6AP1 (Ac45) regulates osteoclast differentiation, extracellular acidification, lysosomal trafficking, and protease exocytosis in osteoclast-mediated bone resorption.J Bone Miner Res. 2012 Aug;27(8):1695-707. doi: 10.1002/jbmr.1623. J Bone Miner Res. 2012. PMID: 22467241 Free PMC article.
-
Protein kinase C-delta deficiency perturbs bone homeostasis by selective uncoupling of cathepsin K secretion and ruffled border formation in osteoclasts.J Bone Miner Res. 2012 Dec;27(12):2452-63. doi: 10.1002/jbmr.1701. J Bone Miner Res. 2012. PMID: 22806935 Free PMC article.
-
Aesculetin Inhibits Osteoclastic Bone Resorption through Blocking Ruffled Border Formation and Lysosomal Trafficking.Int J Mol Sci. 2020 Nov 13;21(22):8581. doi: 10.3390/ijms21228581. Int J Mol Sci. 2020. PMID: 33203061 Free PMC article.
-
Modulation of osteoclast differentiation and bone resorption by Rho GTPases.Small GTPases. 2014;5:e28119. doi: 10.4161/sgtp.28119. Epub 2014 Mar 10. Small GTPases. 2014. PMID: 24614674 Free PMC article. Review.
-
The role of cathepsin K in normal bone resorption.Drug News Perspect. 2004 Jan-Feb;17(1):19-28. doi: 10.1358/dnp.2004.17.1.829022. Drug News Perspect. 2004. PMID: 14993931 Review.
Cited by
-
Characterization of New Proteomic Biomarker Candidates in Mucopolysaccharidosis Type IVA.Int J Mol Sci. 2020 Dec 28;22(1):226. doi: 10.3390/ijms22010226. Int J Mol Sci. 2020. PMID: 33379360 Free PMC article.
-
Differential proteomic analysis of tibial subchondral bone from male and female guinea pigs with spontaneous osteoarthritis.Exp Ther Med. 2021 Jun;21(6):633. doi: 10.3892/etm.2021.10065. Epub 2021 Apr 15. Exp Ther Med. 2021. PMID: 33968164 Free PMC article.
-
Gene expression in notochord and nuclei pulposi: a study of gene families across the chordate phylum.BMC Ecol Evol. 2023 Oct 27;23(1):63. doi: 10.1186/s12862-023-02167-1. BMC Ecol Evol. 2023. PMID: 37891482 Free PMC article.
-
Overview of multifunctional cysteinyl cathepsins in atherosclerosis-based cardiovascular disease: from insights into molecular functions to clinical implications.Cell Biosci. 2023 May 19;13(1):91. doi: 10.1186/s13578-023-01040-4. Cell Biosci. 2023. PMID: 37202785 Free PMC article. Review.
-
Cationic Hydroxyethyl Cellulose Nanocomplexes and RANK siRNA/Zoledronate Co-Delivery Systems for Osteoclast Inhibition.Pharmaceutics. 2024 Dec 22;16(12):1623. doi: 10.3390/pharmaceutics16121623. Pharmaceutics. 2024. PMID: 39771601 Free PMC article.
References
-
- Suda T. et al.. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20, 345–357 (1999). - PubMed
-
- Boyle W. J., Simonet W. S. & Lacey D. L. Osteoclast differentiation and activation. Nature 423, 337–342 (2003). - PubMed
-
- Asagiri M. & Takayanagi H. The molecular understanding of osteoclast differentiation. Bone 40, 251–264 (2007). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources